Skip to Content

BRCA1 and BRCA2 Gene Mutation Detection Kit – 12 Tests/Kit

The BRCA1 and BRCA2 Gene Mutation Detection Kit is a molecular assay designed for the detection of clinically relevant mutations in the BRCA1 and BRCA2 genes, two key biomarkers associated with hereditary breast and ovarian cancer. This kit supports early risk assessment, patient stratification, and personalized treatment planning in both clinical and research settings.

Key Features

  • Comprehensive mutation coverage
    Detects a wide range of clinically significant BRCA1 and BRCA2 mutations, supporting risk evaluation in hereditary breast and ovarian cancer syndromes.
  • High analytical performance
    PCR-based detection provides high sensitivity and specificity, ensuring reliable identification of mutant alleles from patient DNA samples.
  • Ready-to-use format
    Supplied with reagents and controls for 12 tests per kit, simplifying setup and standardizing assay performance across runs.
  • Versatile sample compatibility
    Compatible with DNA extracted from blood or tissue samples, fitting seamlessly into existing molecular workflows.
  • User-friendly workflow
    Streamlined protocol suitable for clinical and research laboratories, reducing hands-on time and technical complexity.
  • Clinical utility
    Facilitates early risk assessment in individuals with a family history of breast or ovarian cancer, enabling informed decisions about surveillance and preventive strategies (e.g., prophylactic measures, targeted therapies).

Applications

  • Detection of BRCA1/BRCA2 gene mutations
  • Hereditary breast and ovarian cancer (HBOC) risk assessment
  • Patient selection and stratification for targeted therapies (e.g., PARP inhibitors, where applicable)
  • Genetic counseling support in oncology and preventive medicine
  • Clinical research and translational studies in cancer genetics

Product Specifications

  • Target genes: BRCA1 and BRCA2
  • Detection method: PCR-based mutation detection
  • Number of tests: 12 tests/kit
  • Sample types: Genomic DNA from blood or tissue
  • Intended use: Research Use Only (RUO) or as per local regulatory status